DEF 14AThe Ballot
Xeris Biopharma Holdings, Inc. files DEF 14A
Filed Apr 28, 2022 · 4y ago · Accession 0001867096-22-000047
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- XERS
- CIK
- 1867096
- Form type
- DEF 14A
- Filing date
- Apr 28, 2022
- Report date
- Dec 31, 2021
- Document
- a2022proxystatement.htm
- Size
- 795 KB